| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.512.451 | 21.548.029 | 20.923.035 | 23.378.795 | 21.237.247 | 17.949.122 | 15.930.665 | 19.282.286 | 32.639.632 | 34.195.285 |
| Total Income - EUR | 20.869.825 | 22.143.805 | 21.318.611 | 23.815.858 | 21.575.260 | 18.277.238 | 16.197.991 | 19.997.825 | 38.198.531 | 35.974.733 |
| Total Expenses - EUR | 18.848.911 | 21.826.143 | 20.684.679 | 22.450.525 | 19.393.895 | 16.517.707 | 14.924.738 | 18.071.881 | 34.720.659 | 31.895.181 |
| Gross Profit/Loss - EUR | 2.020.914 | 317.662 | 633.932 | 1.365.333 | 2.181.365 | 1.759.531 | 1.273.253 | 1.925.944 | 3.477.872 | 4.079.553 |
| Net Profit/Loss - EUR | 1.197.986 | -524.026 | -251.158 | 602.111 | 1.490.539 | 1.225.690 | 980.028 | 1.374.901 | 2.586.018 | 3.135.874 |
| Employees | 109 | 117 | 122 | 122 | 121 | 112 | 123 | 236 | 258 | 292 |
Check the financial reports for the company - Abbvie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.971.288 | 4.220.739 | 2.599.739 | 1.568.901 | 1.308.196 | 1.486.337 | 1.146.053 | 1.637.897 | 1.515.606 | 2.122.537 |
| Current Assets | 11.726.844 | 13.175.989 | 14.253.683 | 14.593.976 | 15.605.128 | 17.062.904 | 17.343.319 | 19.963.795 | 25.329.402 | 27.514.858 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.757.760 | 4.420.079 | 5.438.968 | 5.162.441 | 7.392.552 | 4.786.310 | 5.190.029 | 6.748.144 | 3.405.794 | 8.065.601 |
| Cash | 0 | 3.286.455 | 1.472.560 | 2.768.002 | 1.166.296 | 0 | 0 | -1.410 | 0 | -9 |
| Shareholders Funds | 12.941.587 | 12.285.575 | 11.826.524 | 12.211.597 | 13.465.644 | 14.436.058 | 15.095.953 | 16.781.020 | 19.441.451 | 22.674.056 |
| Social Capital | 11.248.639 | 11.133.918 | 10.945.513 | 10.744.644 | 10.536.562 | 10.336.813 | 10.107.585 | 10.239.128 | 10.208.078 | 10.151.028 |
| Debts | 4.595.755 | 4.504.778 | 3.937.923 | 3.564.012 | 3.082.419 | 3.042.934 | 2.818.047 | 4.390.452 | 6.862.999 | 6.062.470 |
| Income in Advance | 0 | 0 | 0 | 0 | 31.838 | 23.434 | 22.915 | 15.157 | 15.111 | 15.026 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8299 - 8299" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Abbvie Srl